- Hassan Researcher Activity Profile

Research Author Detailed Information 

Hassan Publication Rate By Year

Hassan has published 1 paper(s) in 1980, 1 paper(s) in 1983, 1 paper(s) in 1987, 1 paper(s) in 1991, 1 paper(s) in 2003, 1 paper(s) in 2004, 5 paper(s) in 2006, 22 paper(s) in 2007, 3 paper(s) in 2008, for a total of 36 research publications in total.

R Hassan Author Information

LAST NAME: hassan

FIRST NAME:

INITIALS: r

AFFILIATION:

Papers

Hassan's Publication Record

1. Epidemiology of virus-associated cancers in Brazil. Year Published: 2006
2. Synergistic antitumor activity of taxol and immunotoxin SS1P in tumor-bearing mice. Year Published: 2006
Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892-4264, USA.
3. Characterization of the B cell epitopes associated with a truncated form of Pseudomonas exotoxin (PE38) used to make immunotoxins for the treatment of cancer patients. Year Published: 2006
Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 37 Convent Drive, Bethesda, MD 20892, USA.
4. Fuzzy Logic-based Recognition of Gait Changes due to Trip-related Falls. Year Published: 2007
Dept. of Computer Science & Software Engineering, The University of Melbourne, Carlton, Vic 3010, Australia.
5. Mesothelin, a possible target for immunotherapy, is expressed in primary AML cells. Year Published: 2007
University Children's Hospital Jena, Germany. Daniel@Steinba.ch
6. Structural variability of the carboxy-terminus of Epstein-Barr virus encoded latent membrane protein 1 gene in Hodgkin's lymphomas. Year Published: 2007
7. HMM-Fuzzy Model for Recognition of Gait Changes due to Triprelated Falls. Year Published: 2007
Dept. of Comput. Sci. & Software Eng., Melbourne Univ., Carlton, Vic.
8. Immunotoxin and Taxol synergy results from a decrease in shed mesothelin levels in the extracellular space of tumors. Year Published: 2007
Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
9. Evidence for Physical Interaction between the Immunoglobulin Heavy Chain Variable Region and the 3' Regulatory Region. Year Published: 2007
Department of Cell Biology, Albert Einstein College of Medicine, Bronx, New York 10461.
10. Prognostic impact of CD15 expression and proliferative index in the outcome of children with classical Hodgkin lymphoma. Year Published: 2007
11. Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelin. Year Published: 2007
Laboratory of Molecular Biology, National Cancer Institute, Bethesda, MD, USA.
12. Prognostic impact of CD15 expression and proliferative index in the outcome of children with classical Hodgkin lymphoma. Year Published: 2007
13. Mesothelin, a possible target for immunotherapy, is expressed in primary AML cells. Year Published: 2007
University Children's Hospital Jena, Germany. Daniel@Steinba.ch
14. Synergistic antitumor activity of taxol and immunotoxin SS1P in tumor-bearing mice. Year Published: 2006
Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892-4264, USA.
15. Mesothelin targeted cancer immunotherapy. Year Published: 2007
Solid Tumor Immunotherapy Section, Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 37 Convent Drive, Room 5116, Bethesda, MD 20892-4264, USA.
16. Interaction between Hck and HIV-1 Nef negatively regulates cell surface expression of M-CSF receptor. Year Published: 2007
17. Evidence for physical interaction between the immunoglobulin heavy chain variable region and the 3' regulatory region. Year Published: 2007
Department of Cell Biology, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
18. Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelin. Year Published: 2007
Morphotek Inc., 210 Welsh Pool Road, Exton, PA, USA.
19. Anti-mesothelin immunotoxin SS1P in combination with gemcitabine results in increased activity against mesothelin-expressing tumor xenografts. Year Published: 2007
Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, and the Clinical Center, NIH, Bethesda, Maryland 20892, USA. hassanr@mail.nih.gov
20. Prognostic impact of CD15 expression and proliferative index in the outcome of children with classical Hodgkin lymphoma. Year Published: 2007
21. Interaction between Hck and HIV-1 Nef negatively regulates cell surface expression of M-CSF receptor. Year Published: 2007
Division of Hematopoiesis, Center for AIDS Research, Kumamoto University, Honjo 2-2-1, Kumamoto-city, Kumamoto 860-0811, Japan.
22. Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelin. Year Published: 2007
Morphotek Inc., 210 Welsh Pool Road, Exton, PA, USA.
23. Evidence for physical interaction between the immunoglobulin heavy chain variable region and the 3' regulatory region. Year Published: 2007
Department of Cell Biology, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
24. HMM-Fuzzy model for recognition of gait changes due to trip-related falls. Year Published: 2007
Department of Computer Science and Software Engineering, University of Melbourne, Carlton, Victoria 3010, Australia. mrhassan@cse.unimelb.edu.au
25. Diagnosis of typhoid fever by Dot enzyme immunoassay in an endemic region. Year Published: 2003
Departments of Pathology and Community Health Sciences, Aga Khan University Hospital, Karachi.
26. Immunogenicity of yeast-derived hepatitis B vaccine in Pakistani adults. 1990. Year Published: 2004
27. Bile salt, phospholipids and cholesterol in bile of patients with cholelithiasis. Year Published: 1980
28. Nutritional aspects of hepatic coma. Year Published: 1983
29. Choice of diuretics in cirrhosis with ascites. Year Published: 1987
30. Hepatotoxicity to different antituberculosis drug combinations. Year Published: 1991
PMRC Research Centre, Jinnah Postgraduate Medical Centre, Karachi.
31. Eliciting explanatory models of common mental disorders using the Short Explanatory Model Interview (SEMI) Urdu adaptation--a pilot study. Year Published: 2006
Institute of Psychiatry, de Crespigny Park, Denmark Hill, London.
32. Mesothelin targeted cancer immunotherapy. Year Published: 2007
Solid Tumor Immunotherapy Section, Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892-4264, USA. hassanr@mail.nih.gov
33. Interaction between Hck and HIV-1 Nef negatively regulates cell surface expression of M-CSF receptor. Year Published: 2007
Division of Hematopoiesis, Center for AIDS Research, Kumamoto University, Honjo 2-2-1, Kumamoto-city, Kumamoto 860-0811, Japan.
34. Tropical pulmonary eosinophilia in a patient undergoing open heart surgery. Year Published: 2008
Dr Tahmina Shirin, Associate Professor, Clinical Immunology, NIKDU, Dhaka, Bangladesh; E-mail: drshirin68@yahoo.com.
35. Burkitt lymphoma/leukaemia transformed from a precursor B cell: clinical and molecular aspects. Year Published: 2008
Bone Marrow Transplantation Centre (CEMO), Instituto Nacional de Câncer (INCA), Rio de Janeiro, Brazil.
36. Clinical and laboratorial prediction of bone marrow involvement in children and adolescents with Hodgkin Lymphoma. Year Published: 2008